News

Melanoma at 33: A Testament to the Importance of Early Detection

By Renee Orcione, MRA Development Associate | 23 January 2023 In Melanoma Stories

Before he landed his current office job in the energy sector, Matthew Ruiz worked outdoors for many years. He, along with many of his colleagues in the field, took very few precautions to protect themselves from harmful UV rays. As is the unfortunate reality for many people with a history of significant sun exposure, this lifestyle came full circle for Matthew in 2018 when he was diagnosed with melanoma.

Read More


Nearly 100,000 Americans Estimated to be Diagnosed with Melanoma in 2023

By Joan Levy, PhD - MRA Chief Science Officer | 19 January 2023 In News, Prevention, Science, Treatment

Each January, the American Cancer Society (ACS) releases updated estimates about trends in new cancer cases and deaths in its annual report, Cancer Facts and Figures. This report highlights the estimated incidence (number of new cases), prevalence (number of people alive today with a history of cancer), and survival statistics for cancer in the United States.

Read More


Registration Now Open: MRA's 2023 Patient Forum

19 January 2023 In Allies & Partnerships, Events, News, Prevention, Science, Treatment

Registration for MRA's Melanoma Exchange Patient Forum, held in-person in Washington DC and virtually on Wednesday, March 8, is now open. Register now to hear from leading experts in the melanoma field and have the opportunity to ask questions, discuss, and network with other people who are going through their own melanoma journey.

Read More


Pioneering New Treatment Strategies for Melanoma

11 January 2023

Over the last few decades, the melanoma research community has made tremendous progress detecting several genes that when altered cause melanoma, including those involved in melanoma’s growth and development. In addition, scientists have uncovered key enzymes that regulate the expression of critical tumor-associated genes — called epigenetic factors.

Read More


Ask the Experts: Melanoma Research Update

8 December 2022

From promising clinical trial results to new treatment approaches and an evolving standard of care, 2022 has proven to be an exciting year of advances in melanoma research. As MRA continues to look ahead, we also want to take a moment to reflect on these advances and what they mean for melanoma patients, families, and the community at large.

Read More


More Time, More Research, More Hope: Double your Impact!

29 November 2022 In Allies & Partnerships, Events, News

To share their gratitude for all those who are making a difference in melanoma research, our founders — Debra & Leon Black — are matching all gifts* to MRA up to $1 MILLION this holiday season. Donate Today!

Read More


Artificial Intelligence & Melanoma Detection: Closing the Gaps

15 November 2022

The earlier a cancer is detected, the better the patient’s prognosis. However, detecting melanoma isn't always clear cut. We currently identify melanoma based on subjective visual criteria and accuracy varies greatly from practitioner to practitioner and clinic to clinic. Artificial intelligence has the potential to improve this, but isn't quite ready for primetime.

Read More


From Melanoma Patient to Caregiver

By Renee Orcione, MRA Development Associate | 11 November 2022

By the time she was 26-years old, Leah Adams had spent countless hours tanning. Growing up in Ohio where the winters were long, she felt a pressure to stay tan far beyond the summer months, so she turned to tanning beds.

Read More


The Changing Melanoma Landscape

7 November 2022

Before 2011, the melanoma treatment arena was in a sustained drought during which patients were only offered a few treatments, and few with advanced stages of the cancer were still alive a year after starting treatment.

Read More


Facing Melanoma Together: Kate O'Neil

31 October 2022

Prior to the creation of modern melanoma therapies, Kate O'Neil's sister Noreen was diagnosed, treated, and ultimately passed away from the disease. To honor her sister's legacy, Kate has become a champion of melanoma research.

Read More


Login

×